Financial Summary for the Fiscal Period Ending March 2026 [Japanese GAAP] (Consolidated)

Overview of Performance

Morinaga Milk Industry Group focused on growth areas such as yogurt, ice cream, and Bifidobacteria, concentrating management resources under the 'Mid-term Management Plan 2025-28' to expand earnings. For the fiscal year ending March 2026, amid increased costs driven by higher trading prices for raw milk used in dairy products domestically, rising raw material and logistics costs, the company pursued price revisions and expanded high-value-added products. As a result, consolidated net sales reached 571,458 million yen (up 1.8% YoY), operating profit was 34,479 million yen (up 16.3% YoY), and net income attributable to owners of the parent was 22,599 million yen (up 313.9% YoY). Domestic operations implemented price revisions for yogurt, ice cream, and beverages, while sales volume decreased. Overseas, overall sales grew due to increased revenue from MILEI GmbH.

Dividends and Stock Split

The annual dividend for the fiscal year ending March 2026 is projected at 100 yen (interim 45 yen, year-end 55 yen), with a payout ratio of 36.2%. A stock split of 4 shares per 1 share of common stock will be effective from July 1, 2026, and the projected dividend per share for the fiscal year ending March 2027, considering the stock split, is 25 yen. The company aims for stable and long-term dividends following the stock split.

Earnings Forecast for the Fiscal Year Ending March 2027

For the fiscal year ending March 2027, the company expects net sales of 580 billion yen (up 1.5% YoY), operating profit of 32 billion yen (down 7.2% YoY), ordinary income of 32.7 billion yen (down 11.9% YoY), and net income attributable to owners of the parent of 20 billion yen (down 11.5% YoY). Growth in overseas segments such as probiotic and baby milk products will continue, although increased costs are expected due to higher raw material prices. Considering the impact of the stock split, projected net income per share is 61.96 yen.